Nauwelaers Inne, Laudus Nele, Peeters Dieter, Acs Balazs, Denkert Carsten, Michiels Stefan, Horlings Hugo, Siziopikou Kalliopi P, Ely Scott, Zardavas Dimitrios, Mustimbo Roberts, Bartlett John, Floris Giuseppe, Hartman Johan, van Deurzen Carolien H M, Ceusters Dorien, Dequeker Els, Salgado Roberto
Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, University of Leuven, Kapucijnenvoer 35d, 3000 Leuven, Belgium.
CellCarta NV, 2610 Antwerp, Belgium.
Cancers (Basel). 2022 Aug 2;14(15):3762. doi: 10.3390/cancers14153762.
Increasing data suggests that an intact immune system is required for improvedoutcomes in patients with Human Epidermal Growth Factor Receptor 2 (HER2+) and Triple Negative Breast Cancer (TNBC) [...].
越来越多的数据表明,对于人表皮生长因子受体2(HER2+)和三阴性乳腺癌(TNBC)患者而言,完整的免疫系统是改善预后所必需的[...]。